Farmindustria and employees warns of Italian job threats
This article was originally published in Scrip
As the Italian parliament prepares to sign off Mario Monti's latest Spending Review, voices from across industry have are being raised to warn of the serious threat it presents to the viability of the nation's biopharmaceutical sector.
You may also be interested in...
BioNTech extends Pfizer partnership to cover COVID-19 vaccine development and distribution while Fosun Pharma takes Chinese rights.
Dietmar Hopp, 80% shareholder of German mRNA company CureVac, has rejected the possibility that the company would sign an exclusive deal with the US for its investigational coronavirus vaccine.
Infographic: Scrip homes in on key figures for companies integrating major acquisitions or divesting significant parts of their business.